These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The lupus inhibitor: a study of its heterogeneity. Coots MC; Miller MA; Glueck HI Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826 [TBL] [Abstract][Full Text] [Related]
25. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation. de Araújo RM; Vaz AF; Santos ME; Zingali RB; Coelho LC; Paiva PM; Correia MT; Oliva ML; Ferreira RS Thromb Res; 2011 Oct; 128(4):395-7. PubMed ID: 21752431 [No Abstract] [Full Text] [Related]
26. Influence of factor VII on the assay of factor VIII by the one stage method using wettable surface. Altman R; Rouvier J; Reussi C Thromb Diath Haemorrh; 1972 Dec; 28(3):457-63. PubMed ID: 4675266 [No Abstract] [Full Text] [Related]
27. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII). Niwano H; Embury PB; Greenberg BD; Ratnoff OD J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473 [TBL] [Abstract][Full Text] [Related]
28. Basic mechanisms in blood coagulation. Davie EW; Fujikawa K Annu Rev Biochem; 1975; 44():799-829. PubMed ID: 237463 [No Abstract] [Full Text] [Related]
29. NATURE AND ACTION OF INTERMEDIATE PRODUCT I. SPAET TH Fed Proc; 1964; 23():757-61. PubMed ID: 14195459 [No Abstract] [Full Text] [Related]
33. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording. Joist JH; Cowan JF; Khan M J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667 [TBL] [Abstract][Full Text] [Related]
34. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X). Seegers WH; Grammens GL; McCoy LE Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980 [No Abstract] [Full Text] [Related]